Fitness

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members…

4 weeks ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight management has undergone a seismic…

1 month ago

Interactive Strength Inc. (NASDAQ: TRNR) Secures New $200k+ Wattbike Order From Fitness First in Germany

Driven by rollout of the next-generation Wattbike AIR-PRO across Germany's Fitness First's premium Black Label facilitiesMajor order follows April's $1M+…

1 month ago

Omega Healthcare Named a Leader in the 2025-2026 IDC MarketScape for U.S. Revenue Cycle Management Service Solutions

BOCA RATON, Fla., Dec. 10, 2025 /PRNewswire/ -- Omega Healthcare, a leading provider of technology-driven healthcare solutions, today announced it was…

1 month ago

Mindbody and Attentive Commercial Partnership Brings Enterprise-Grade AI Marketing to the Wellness Industry

Integration brings best-in-class SMS and email into Mindbody, powering personalized outreach that drives engagement and revenue for fitness and wellness…

1 month ago

Eagle Merchant Partners Portfolio Company Aligned Fitness Acquires 13 Club Pilates Studios

ATLANTA, Dec. 9, 2025 /PRNewswire/ -- Eagle Merchant Partners portfolio company, Aligned Fitness, has recently completed four add-on acquisitions comprising of…

1 month ago

Qualia Life Sciences, Award-Winning Supplement Brand, Celebrates Its 10th Year Anniversary

With Human Studies On Every Formula, Qualia's Industry-Leading Research Standards Are Fueling Innovation and Rapid GrowthCARLSBAD, Calif., Dec. 9, 2025…

1 month ago

Fitasy Unveils Breakthrough Technology Making Custom-Fit 3D Printed Shoes More Accessible and Affordable, Supporting Better Foot Health

Fitasy is set to transform the footwear industry with new technology that democratizes access to custom-fit shoes—improving comfort, reducing waste,…

1 month ago

Earlier use of CARVYKTI®▼ (ciltacabtagene autoleucel) demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single…

1 month ago